Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I'm very confused?

"In hindsight the BOD made some ill advised moves (from a shareholder's point of view) in partnering with TPL, Schwartz warrants, etc."

1. Can you give reasons, why the partnering with Moore (and TPL, which was the partner of Moore then) was a bad move? At that time the MMP was divided in two halfs - not before both entities joined forces it was able to start the licensing work, so far successful with about $250mio license fees.

2. Can you give reasons, how PTSC could have survived the years between 2000 and 2005 without the funding of Swartz? Take a closer look at "all" the companies which emerged in the 90ies while the "dotcom-boom"- and which of these companies are still there today: more than 90% of it have vanished (destroyed or bought up).

Nevertheless you bring up an interesting point regarding the possible parting of PTSC and TPL:
My guess is, if Moore cancels his agreement with TPL and PTSC doing the same TPL would be out of the game. But I must confess it's a long time since I read the agreements between these three parties, so maybe there's a default process for this scenario?

GLTY

Share
New Message
Please login to post a reply